Identification of clinical prognostic features of esophageal cancer based on m6A regulators
暂无分享,去创建一个
Yuanji Xu | Yiping Zhang | Lin Chen | Yufeng Liu | Huimei Wang | Junqiang Chen | Yuanmei Chen | Chen Xu | Yu Lin | Haixing Wang | Q. Song | Yingyong Hou | D. Jiang | Li-Yuan Wang
[1] B. Shan,et al. METTL3 Facilitates Tumor Progression by COL12A1/MAPK Signaling Pathway in Esophageal Squamous Cell Carcinoma , 2022, Journal of Cancer.
[2] Jianping Zhang,et al. Flap endonuclease 1 Facilitated Hepatocellular Carcinoma Progression by Enhancing USP7/MDM2-mediated P53 Inactivation , 2022, International journal of biological sciences.
[3] Mingxin Zhang,et al. Recent advances of m6A methylation modification in esophageal squamous cell carcinoma , 2021, Cancer cell international.
[4] Kecheng Zhang,et al. N6-methyladenosine demethylase ALKBH5 suppresses malignancy of esophageal cancer by regulating microRNA biogenesis and RAI1 expression , 2021, Oncogene.
[5] Jieyi Ma,et al. METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway , 2021, Molecular therapy. Nucleic acids.
[6] Donghong Zhang,et al. HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 Cluster , 2021, Frontiers in Cell and Developmental Biology.
[7] F. Tan,et al. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma , 2021, Frontiers in Immunology.
[8] Cui Wang,et al. MicroRNA-454-3p inhibits cell proliferation and invasion in esophageal cancer by targeting insulin-like growth factor 2 mRNA-binding protein 1 , 2020, Oncology letters.
[9] X. Zou,et al. m6A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1 , 2020, Frontiers in Oncology.
[10] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[11] Jing-xin Pan,et al. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer , 2020, Cancer management and research.
[12] Xiaoming Yu,et al. METTL3 promotes the proliferation and invasion of esophageal cancer cells partly through AKT signaling pathway. , 2020, Pathology, research and practice.
[13] Hao Yu,et al. Mechanism of RNA modification N6-methyladenosine in human cancer , 2020, Molecular Cancer.
[14] S. Motoyama,et al. m6 A demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis. , 2020, Genes to cells : devoted to molecular & cellular mechanisms.
[15] Jianjun Chen,et al. m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. , 2020, Cancer cell.
[16] Meijuan Huang,et al. FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13. , 2020, Experimental cell research.
[17] Gang Yin,et al. Functions of N6-methyladenosine and its role in cancer , 2019, Molecular Cancer.
[18] J. Que,et al. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer. , 2019, Cancer letters.
[19] Q. Xue,et al. Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy , 2019, Annals of Surgical Oncology.
[20] Yassen Assenov,et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer , 2018, Genome research.
[21] J. Mesirov,et al. The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .
[22] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[23] Matthew D. Wilkerson,et al. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..
[24] S. Leung,et al. Insulin-Like Growth Factor Binding Protein-2 Is a Novel Therapeutic Target Associated with Breast Cancer , 2008, Clinical Cancer Research.
[25] E. Lander,et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.